CASP8 and inborn error of immunity: Loss of function mutations preventing kinase activity of RIPK1 itself as well as heterozygous Casp8 cleavage-site mutations allowing unregulated activity of RIPK1 cause severe primary immunodeficiency, intestinal inflammation, arthritis, and CRIA in humans (1, 30).